Machine learning for adverse event prediction in outpatient parenteral antimicrobial therapy: a scoping review

被引:1
|
作者
Challener, Douglas W. [1 ]
Fida, Madiha [1 ]
Martin, Peter [2 ]
Rivera, Christina G. [3 ]
Virk, Abinash [1 ]
Walker, Lorne W. [4 ,5 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA
[3] Mayo Clin, Dept Pharm, Rochester, MN USA
[4] Oregon Hlth & Sci Univ, Div Pediat Infect Dis, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA
关键词
ANTIBIOTIC-THERAPY; RISK-FACTORS; HEALTH-CARE; VANCOMYCIN; INFUSION; READMISSIONS; DAPTOMYCIN; MODEL; OPAT;
D O I
10.1093/jac/dkae340
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective This study aimed to conduct a scoping review of machine learning (ML) techniques in outpatient parenteral antimicrobial therapy (OPAT) for predicting adverse outcomes and to evaluate their validation, implementation and potential barriers to adoption.Materials and methods This scoping review included studies applying ML algorithms to adult OPAT patients, covering techniques from logistic regression to neural networks. Outcomes considered were medication intolerance, toxicity, catheter complications, hospital readmission and patient deterioration. A comprehensive search was conducted across databases including Cochrane Central, Cochrane Reviews, Embase, Ovid MEDLINE and Scopus, from 1 January 2000 to 1 January 2024.Results Thirty-two studies met the inclusion criteria, with the majority being single-centre experiences primarily from North America. Most studies focused on developing new ML models to predict outcomes such as hospital readmissions and medication-related complications. However, there was very little reporting on the performance characteristics of these models, such as specificity, sensitivity and C-statistics. There was a lack of multi-centre or cross-centre validation, limiting generalizability. Few studies advanced beyond traditional logistic regression models, and integration into clinical practice remains limited.Discussion ML shows promise for enhancing OPAT outcomes by predicting adverse events and enabling pre-emptive interventions. Despite this potential, significant gaps exist in development, validation and practical implementation. Barriers include the need for representative data sets and broadly applicable, validated models.Conclusion Future research should address these barriers to fully leverage ML's potential in optimizing OPAT care and patient safety. Models must deliver timely, accurate and actionable insights to improve adverse event prediction and prevention in OPAT settings.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 50 条
  • [21] Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections
    Felder, Kimberly K.
    Marshall, Lynn M.
    Vaz, Louise E.
    Barnes, Penelope D.
    SOUTHERN MEDICAL JOURNAL, 2016, 109 (01) : 53 - 60
  • [22] Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
    Underwood, Jonathan
    Marks, Michael
    Collins, Steve
    Logan, Sarah
    Pollara, Gabriele
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (03) : 787 - 790
  • [23] Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy
    Durojaiye, O. C.
    Kritsotakis, E. I.
    Johnston, P.
    Kenny, T.
    Ntziora, F.
    Cartwright, K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (07) : 905.e1 - 905.e7
  • [24] Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy
    Benefield, RussellJ. J.
    McDonald, Joshua
    Newman, Michael
    Tritle, Brandon
    Certain, Laura K. K.
    PHARMACOTHERAPY, 2023, 43 (09): : 894 - 903
  • [25] Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care
    Yang, Anjie
    Fung, Ron
    Brunton, James
    Dresser, Linda
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (02) : 74 - 78
  • [26] Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy
    Ingram, Paul R.
    Lye, David C.
    Fisher, Dale A.
    Goh, Wei-Ping
    Tam, Vincent H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (06) : 570 - 574
  • [27] An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
    Bradley, Abby C.
    Wingler, Mary Joyce B.
    Artman, Katherine L.
    Ward, Lori M.
    Lucar, Jose
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2023, 10
  • [28] Outpatient parenteral antimicrobial therapy: Recent developments and future prospects
    Torok, M. Estee
    Chapman, Ann L. N.
    Lessing, M. P. Albert
    Sanderson, Frances
    Seaton, R. Andrew
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (08) : 929 - 939
  • [29] Recent innovations and new applications of outpatient parenteral antimicrobial therapy
    Farmer, Eoghan Charles William
    Seaton, Ronald Andrew
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (01) : 55 - 64
  • [30] Safety of Outpatient Parenteral Antimicrobial Therapy in Children
    Fernandes, Priyanka
    Milliren, Carly
    Mahoney-West, Helen M.
    Schwartz, Laura
    Lachenauer, Catherine S.
    Nakamura, Mari M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (02) : 157 - 163